FDA
approval
· 2021-10-07
FDA Approved: EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Camber Pharmaceuticals, Inc.)
Summary
The FDA approved Camber Pharmaceuticals' original-application generic combination emtricitabine and tenofovir disoproxil fumarate for treatment of HIV-1 infecti…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE (EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)